Results revealed that decreased DUSP2 expression was associated with a higher T stage, a higher Gleason score, and a higher incidence of lymph node metastases (Figures 8A–C, Supplementary Table 3). Here, DUSP2 is linked to metastatic malignant neoplasm in the lymph nodes.